In MASLD cases with increased FGF21 expression TSC2 was markedly down‐regulated, and the negative correlation between FGF21 and TSC1 or TSC2 was significant. The gene discussed is TSC2; the disease is metabolic dysfunction-associated steatotic liver disease.